Literature DB >> 8428402

Abnormal urinary protein excretion in HIV-infected patients.

P L Kimmel1, W O Umana, J P Bosch.   

Abstract

HIV infection has been associated with a variety of renal diseases, although the pathogenesis of such dysfunction is unknown. To determine whether HIV-infection is associated with glomerular permeability defects, and if so, the prevalence of the finding, we studied patients with various stages of HIV infection. Urine samples from 505 outpatients with HIV infection (without hypertension, azotemia, or dipstick proteinuria), 41 normal controls and 40 febrile non-HIV positive, hospitalized patients with infectious diseases were analyzed for the urinary microalbumin/creatinine ratio (U microA/Cr), a sensitive indicator of incipient renal disease in diabetes mellitus and hypertension, and the urinary beta 2-microglobulin/creatinine ratio (U beta 2/Cr), an indicator of renal tubular function. Microalbumin concentration was measured by ELISA. Beta 2-microglobulin concentration was measured by an enzyme immunoassay. HIV-infected outpatients had higher mean U microA/Cr than normal subjects, but not febrile hospitalized controls. The prevalence of an increased U microA/Cr was 29.8% in the HIV-infected outpatient population. There was no difference in the ratio between Black and White HIV-infected outpatients, HIV-infected outpatients treated or untreated with zidovudine (AZT), or HIV infected outpatients untreated with any drug. There was no difference between U microA/Cr in stage II, III or IV HIV-infected patients when assessed by analysis of variance. A similar pattern was noted with U beta 2/Cr. The prevalence of an increased U beta 2/Cr ratio was 37.7% in HIV-infected outpatients. Increased urinary albumin and beta 2-microglobulin excretion, not associated with drug therapy, is present in patients with early HIV infection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428402

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  15 in total

1.  Markers of renal disease and function are associated with systemic inflammation in HIV infection.

Authors:  S K Gupta; D Kitch; C Tierney; K Melbourne; B Ha; G A McComsey
Journal:  HIV Med       Date:  2015-05-20       Impact factor: 3.180

2.  Microalbuminuria among HIV-infected antiretroviral therapy-naive children in the Democratic Republic of Congo.

Authors:  Pépé M Ekulu; Michel N Aloni; Jérôme Harambat; Jean Robert R Makulo; François B Lepira; Ernest K Sumaili; Eric M Mafuta; Pierre Cochat; Nazaire M Nseka
Journal:  Pediatr Nephrol       Date:  2015-12-01       Impact factor: 3.714

3.  Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.

Authors:  Christina M Wyatt; Donald R Hoover; Qiuhu Shi; Phyllis C Tien; Roksana Karim; Mardge H Cohen; Johanna L Goderre; Eric C Seaberg; Jason Lazar; Mary A Young; Paul E Klotman; Kathryn Anastos
Journal:  Antivir Ther       Date:  2011

Review 4.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

5.  Human immunodeficiency virus-associated nephropathy (HIVAN) in Nigerian children.

Authors:  Ifeoma C Anochie; Felicia U Eke; Augustina N Okpere
Journal:  Pediatr Nephrol       Date:  2007-11-06       Impact factor: 3.714

6.  The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.

Authors:  Samir K Gupta; Robert A Parker; Gregory K Robbins; Michael P Dubé
Journal:  Nephrol Dial Transplant       Date:  2005-08-16       Impact factor: 5.992

7.  An improved microalbumin method (microALB_2) with extended analytical measurement range evaluated on the ADVIA chemistry systems.

Authors:  Pradip Datta; Amitava Dasgupta
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  Microalbuminuria predicts overt proteinuria among patients with HIV infection.

Authors:  L A Szczech; P Menezes; E Byrd Quinlivan; C van der Horst; J A Bartlett; L P Svetkey
Journal:  HIV Med       Date:  2010-01-04       Impact factor: 3.180

9.  Microalbuminuria in HIV infection.

Authors:  Lynda Anne Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse A Canchola; Charles van der Horst; Stephen Sidney; David Wohl; Michael G Shlipak
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

10.  Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.

Authors:  Christina M Wyatt; Donald R Hoover; Qiuhu Shi; Eric Seaberg; Catherine Wei; Phyllis C Tien; Roksana Karim; Jason Lazar; Mary A Young; Mardge H Cohen; Paul E Klotman; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.